American Portfolios Advisors’s Cymabay Therapeutics CBAY Stock Holding History

American Portfolios Advisors’s Portfolio CBAY Stock Details CBAY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-350	Closed	-$1.59K	–	3467
2021 Q1	$1.59K	Hold	350	–	–	﹤0.01%	3047
2020 Q4	$2.01K	Hold	350	–	–	﹤0.01%	2703
2020 Q3	$2.53K	Hold	350	–	–	﹤0.01%	2516
2020 Q2	$1.22K	Hold	350	–	–	﹤0.01%	2654
2020 Q1	$518	Hold	350	–	–	﹤0.01%	2661
2019 Q4	$686	Sell	350 -380	-52%	-$1.43K	﹤0.01%	2726
2019 Q3	$3.74K	Hold	730	–	–	﹤0.01%	2295
2019 Q2	$5.23K	Buy	730 +380	+109%	+$4.3K	﹤0.01%	2169
2019 Q1	$4.65K	Hold	350	–	–	﹤0.01%	2119
2018 Q4	$2.75K	Buy	+350	New	+$3.33K	﹤0.01%	2057

Other funds holding CBAY

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

FCMI

Foresite Capital Management IV Larkspur, California $290M AUM 143.88% 1-Year Est. Return

FCMI

Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

American Portfolios Advisors's CBAY Position: Q2 2021 in Review

American Portfolios Advisors sold out of Cymabay Therapeutics (CBAY) in Q2 2021, closing a stake of 350 shares — an estimated $1.59K sold.

American Portfolios Advisors first reported a position in CBAY in Q4 2018 and held it in 10 quarters. The position peaked at $5.23K in Q2 2019. 113 funds tracked by Wall St. Rank hold CBAY as of Q2 2021.

American Portfolios Advisors reported no remaining Cymabay Therapeutics position as of Q2 2021 after selling out during the quarter.
American Portfolios Advisors sold 350 Cymabay Therapeutics shares in Q2 2021, an estimated $1.59K.
American Portfolios Advisors first reported a position in Cymabay Therapeutics in Q4 2018 and held it in 10 quarters.
American Portfolios Advisors's Cymabay Therapeutics position peaked at $5.23K in Q2 2019.
113 funds tracked by Wall St. Rank held Cymabay Therapeutics as of Q2 2021.

Based on American Portfolios Advisors's 13F filing for Q2 2021, filed 22 Mar 2023.